Blueprint Medicines (BPMC) Revenue Breakdown: Q1 2025 Business & Regional Performance
Blueprint Medicines (BPMC) reported total revenue of 149.41M USD in Q1 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 86.64% of total revenue. Explore Blueprint Medicines's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.